Clinical Trial Update: Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study evaluating transplantation of human menstrual blood-derived mesenchymal stem cells to treat Type 1 Diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Human menstrual blood-derived mesenchymal stem cells

Snippet

Sponsor: S-Evans Biosciences Co., Ltd. | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN